| Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics LJ Abu-Raddad, L Sabatelli, JT Achterberg, JD Sugimoto, IM Longini Jr, ... Proceedings of the National Academy of Sciences 106 (33), 13980-13985, 2009 | 451 | 2009 |
| Waiting time distributions in financial markets L Sabatelli, S Keating, J Dudley, P Richmond The European Physical Journal B-Condensed Matter and Complex Systems 27, 273-275, 2002 | 230 | 2002 |
| Non-monotonic spontaneous magnetization in a Sznajd-like consensus model L Sabatelli, P Richmond Physica A: Statistical Mechanics and its Applications 334 (1-2), 274-280, 2004 | 48 | 2004 |
| Phase transitions, memory and frustration in a Sznajd-like model with synchronous updating L Sabatelli, P Richmond International Journal of Modern Physics C 14 (09), 1223-1229, 2003 | 36 | 2003 |
| Langevin processes, agent models and socio-economic systems P Richmond, L Sabatelli Physica A: Statistical Mechanics and its Applications 336 (1-2), 27-38, 2004 | 28 | 2004 |
| Modelling heterogeneity and the impact of chemotherapy and vaccination against human hookworm L Sabatelli, AC Ghani, LC Rodrigues, PJ Hotez, S Brooker Journal of the Royal Society Interface 5 (28), 1329-1341, 2008 | 24 | 2008 |
| A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America N Raje, GD Roodman, W Willenbacher, K Shimizu, R García-Sanz, ... Journal of medical economics 21 (5), 525-536, 2018 | 22 | 2018 |
| Cost-effectiveness and Budget Impact of Routine Use of Fractional Exhaled Nitric Oxide Monitoring for the Management of Adult Asthma Patients in Spain L Sabatelli J Investig Allergol Clin Immunol 27 (2), 89-97, 2017 | 21 | 2017 |
| Tafasitamab plus lenalidomide versus 3 rituximab-based treatments for non-transplant eligible relapsed/refractory diffuse large B-cell lymphoma: a matching-adjusted indirect … R Cordoba, T Prawitz, T Westley, A Sharma, S Ambarkhane, ... Advances in Therapy 39 (6), 2668-2687, 2022 | 13 | 2022 |
| Tafasitamab plus lenalidomide versus pola-BR, R2, and CAR T: comparing outcomes from RE-MIND2, an observational, retrospective cohort study in relapsed/refractory diffuse large … GS Nowakowski, DH Yoon, P Mondello, E Joffe, I Fleury, A Peters, R Greil, ... Blood 138, 183, 2021 | 13 | 2021 |
| Selection and quantification of infection endpoints for trials of vaccines against intestinal helminths N Alexander, B Cundill, L Sabatelli, JM Bethony, D Diemert, P Hotez, ... Vaccine 29 (20), 3686-3694, 2011 | 13 | 2011 |
| Relationship between the uncompensated price elasticity and the income elasticity of demand under conditions of additive preferences L Sabatelli Plos one 11 (3), e0151390, 2016 | 11 | 2016 |
| A within-trial cost-effectiveness analysis of panitumumab compared with bevacizumab in the first-line treatment of patients with wild-type RAS metastatic colorectal … CN Graham, A Christodoulopoulou, HN Knox, L Sabatelli, G Hechmati, ... Journal of Medical Economics 21 (11), 1075-1083, 2018 | 9 | 2018 |
| A consensus-based dynamics for market volumes L Sabatelli, P Richmond Physica A: Statistical Mechanics and its Applications 344 (1-2), 62-66, 2004 | 9 | 2004 |
| Peer pressure and generalised lotka volterra models P Richmond, L Sabatelli Physica A: Statistical Mechanics and its Applications 344 (1-2), 344-348, 2004 | 8 | 2004 |
| RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab … GS Nowakowski, DH Yoon, P Mondello, E Joffe, A Peters, I Fleury, R Greil, ... Annals of hematology 102 (7), 1773-1787, 2023 | 6 | 2023 |
| Ponatinib vs. Imatinib as frontline treatment for Philadelphia chromosome-positive acute lymphoblastic leukemia: a matching adjusted indirect comparison JM Ribera, T Prawitz, A Freitag, A Sharma, B Dobi, F Rizzo, L Sabatelli, ... Advances in Therapy 40 (7), 3087-3103, 2023 | 3 | 2023 |
| Estimation of The Health Benefit Associated With A Potential Denosumab-Induced Extension of Progression Free Survival In Multiple Myeloma Patients L Sabatelli, A Jamotte, C Giannopoulou Value in Health 20 (9), A414-A415, 2017 | 2 | 2017 |
| Effect of Heterogeneous Mixing and Vaccination on the Dynamics of Anthelmintic Resistance: A Nested Model L Sabatelli Plos one 5 (5), e10686, 2010 | 2 | 2010 |
| Correction to: RE‑MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola‑BR), CAR‑T therapies, and … GS Nowakowski, DH Yoon, P Mondello, E Joffe, A Peters, I Fleury, R Greil, ... Annals of hematology 102 (9), 2643, 2023 | 1 | 2023 |
